Yasho Industries Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 24 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹5.0K Cr

FY26 volume growth was 33% year-on-year. Volume growth expected between 35% to 45% in FY27, with capacity utilization increasing by about 15%.

From Yasho Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

4,400

Market Cap

₹5.0K Cr

P/E Ratio

95.8

How does Yasho Industries Ltd rank in Chemicals & Petrochemicals?

Compare Yasho Industries Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Yasho Industries Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹246 Cr, net profit ₹12 Cr.

Full financials →

📊 Revenue & Sales Performance

  • FY26 volume growth was 33% year-on-year.
  • FY27 volume growth expected to be between 40% to 50%, driven by 15% increase in capacity utilization.
  • Capacity utilization targeted to ramp up to 75% by FY27.
  • FY28 revenue guidance is approximately INR 1,500 crores, including:
  • - Capacity expansion done in FY26.
  • - Commercialization of a long-term contract/project contributing to growth.
  • Volume growth primarily driven by the industrial segment; consumer segment may see slight dip.
  • Prices stable overall, with some volatility in specific solvents; price increases of 10-15% expected starting FY27.
  • Beyond FY28, growth will be fueled by leveraging current assets at higher utilization (85-90%), introducing new molecules/products, and expanding into performance chemicals beyond traditional segments.

See what Yasho Industries Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

  • FY '26 capex: INR 75 crores, including INR 42 crores at Pakhajan and about INR 7-8 crores at Vapi; INR 25 crores spent on R&D.
  • FY '27 planned capex: INR 125 crores, purely at Pakhajan; no capex contribution from the MNC project (separate).
  • Additional special project at Pakhajan with INR 90 crores capex ongoing.
  • Future capacity expansion at Pakhajan involves building additional production buildings (4 more possible).
  • Long-term contract signed in FY '26 with an advance of INR 51.4 crores; revenue expected from this starting FY '28.
  • No CDMO-style capex; focus on large-volume production (minimum 500-1,000 metric tons).
  • The company aims to reach 75%+ utilization by FY '28, supported by capacity expansions and leveraging strategic contracts.

See what Yasho Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

  • The management did not explicitly mention a current or expected order book value during the call.
  • However, there is reference to commitments from customers based on gained confidence due to supply reliability, supporting the guidance of 70%-75% capacity utilization.
  • A strategic large project for an MNC is expected to start contributing commercially from early FY28, indicating some secured future orders.
  • About 40% of revenue in Q4 FY26 came from contracts with fixed pricing (quarterly or 6-monthly), and 60% from spot or regular customers, implying a mix of confirmed and variable orders.
  • There is no disclosed exact monetary value or backlog figure disclosed for pending orders.
  • Management emphasized healthy demand visibility and customer penetration, but did not quantify order book size.

Key Metrics

Others in Chemicals & Petrochemicals this season

  • NOCIL (Q4 FY26)

    The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…

  • Indo Borax & Chemicals Ltd (Q4 FY26)

    175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…

  • Rossari Biotech (Q4 FY26)

    50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…

  • Pidilite Inds. (Q4 FY26)

    Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Yasho Industries Ltd Q4 FY26 results?

FY26 volume growth was 33% year-on-year. Volume growth expected between 35% to 45% in FY27, with capacity utilization increasing by about 15%.

What is Yasho Industries Ltd share price analysis?

Yasho Industries Ltd currently shows a neutral. The stock trades at a P/E of 95.8 with a market cap of ₹5,013 Cr. Investors should review the full earnings analysis for detailed insights.

Is Yasho Industries Ltd planning capital expenditure?

FY '26 capex: INR 75 crores, including INR 42 crores at Pakhajan and about INR 7-8 crores at Vapi; INR 25 crores spent on R&D.

Keep Yasho Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.